×
About 9,009 results

ALLMedicine Cutaneous Melanoma Center

Research & Reviews  4,285 results

The Melanoma and Breast Cancer Association: An Overview of their 'Second Primary Cancer...
https://doi.org/10.1016/j.critrevonc.2020.102989
Critical Reviews in Oncology/hematology; Jeyakumar A, Chua T et. al.

Jun 2nd, 2020 - This study reviews the relevant epidemiological studies associating cutaneous melanoma and breast carcinomas and provides an overview of the possible genetic, biological and bias factors that underpin this relationship. Standardised incidence rati...

National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma.
https://doi.org/10.21873/anticanres.14325
Anticancer Research; Huayllani MT, Restrepo DJ et. al.

Jun 2nd, 2020 - Acral lentiginous melanoma (ALM) is the least common subtype of cutaneous melanoma and typically occurs on the palms, soles, and nails. Tumor characteristics and disease severity in the US population are not well understood. Our aim was to analyze...

Tumor growth rate as a prognostic factor of acral melanoma in a Korean population.
https://doi.org/10.1097/MD.0000000000019936
Medicine Jo G, Cho SI et. al.

Jun 1st, 2020 - Rapid growth of cutaneous melanoma is associated with aggressive histopathologic features and poor prognosis. However, the impact of growth rate (GR) in acral melanoma (AM) remains largely unknown.We performed this study to identify the impact of ...

Age and Melanocytic Lesions.
https://doi.org/10.1016/j.soc.2020.02.005
Surgical Oncology Clinics of North America; Shannon AB, Song Y et. al.

Jun 1st, 2020 - Age plays a dynamic role in incidence, presentation, and extent of disease for cutaneous melanoma. Even within the spectrum of juvenile melanoma, there exists a range of spitzoid and nonspitzoid melanocytic and melanoma lesions. Spitzoid melanomas...

Adjuvant Therapy for Cutaneous Melanoma.
https://doi.org/10.1016/j.soc.2020.02.009
Surgical Oncology Clinics of North America; Schuitevoerder D, Vining CC et. al.

Jun 1st, 2020 - This article presents the current data supporting adjuvant therapy for patients with cutaneous melanoma. With the recent development of novel immunotherapy agents as well as targeted therapy, there are strong data to support the use of these thera...

see more →

Guidelines  27 results

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/4/article-p367.xml

Mar 31st, 2019 - For adjuvant treatment of melanoma in patients rendered free of disease by surgery, traditional systemic therapy approaches have proven to be ineffective. Adjuvant interferon alfa (IFN alfa), particularly high-dose IFN alfa, has been widely used i...

Guidelines of care for the management of primary cutaneous melanoma.
https://doi.org/10.1016/j.jaad.2018.08.055
Journal of the American Academy of Dermatology; Swetter SM, Tsao H et. al.

Nov 5th, 2018 - The incidence of primary cutaneous melanoma continues to increase each year. Melanoma accounts for the majority of skin cancer-related deaths, but treatment is usually curative following early detection of disease. In this American Academy of Derm...

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immun...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977556
Journal for Immunotherapy of Cancer; Sullivan RJ, Atkins MB et. al.

May 31st, 2018 - Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patien...

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunother...
https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0362-6
Sullivan, R.

May 29th, 2018 - Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patien.

New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distan...
https://doi.org/10.6004/jnccn.2018.0042
Journal of the National Comprehensive Cancer Network : JNCCN; Barker CA, Salama AK

May 22nd, 2018 - The NCCN Guidelines Panel for Melanoma debuted new guidelines for uveal melanoma at the NCCN 23rd Annual Conference. Although uveal melanoma and cutaneous melanoma share the same name, they do have different characteristics and treatments. The NCC...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  4,485 results

The Melanoma and Breast Cancer Association: An Overview of their 'Second Primary Cancer...
https://doi.org/10.1016/j.critrevonc.2020.102989
Critical Reviews in Oncology/hematology; Jeyakumar A, Chua T et. al.

Jun 2nd, 2020 - This study reviews the relevant epidemiological studies associating cutaneous melanoma and breast carcinomas and provides an overview of the possible genetic, biological and bias factors that underpin this relationship. Standardised incidence rati...

National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma.
https://doi.org/10.21873/anticanres.14325
Anticancer Research; Huayllani MT, Restrepo DJ et. al.

Jun 2nd, 2020 - Acral lentiginous melanoma (ALM) is the least common subtype of cutaneous melanoma and typically occurs on the palms, soles, and nails. Tumor characteristics and disease severity in the US population are not well understood. Our aim was to analyze...

Tumor growth rate as a prognostic factor of acral melanoma in a Korean population.
https://doi.org/10.1097/MD.0000000000019936
Medicine Jo G, Cho SI et. al.

Jun 1st, 2020 - Rapid growth of cutaneous melanoma is associated with aggressive histopathologic features and poor prognosis. However, the impact of growth rate (GR) in acral melanoma (AM) remains largely unknown.We performed this study to identify the impact of ...

Age and Melanocytic Lesions.
https://doi.org/10.1016/j.soc.2020.02.005
Surgical Oncology Clinics of North America; Shannon AB, Song Y et. al.

Jun 1st, 2020 - Age plays a dynamic role in incidence, presentation, and extent of disease for cutaneous melanoma. Even within the spectrum of juvenile melanoma, there exists a range of spitzoid and nonspitzoid melanocytic and melanoma lesions. Spitzoid melanomas...

Adjuvant Therapy for Cutaneous Melanoma.
https://doi.org/10.1016/j.soc.2020.02.009
Surgical Oncology Clinics of North America; Schuitevoerder D, Vining CC et. al.

Jun 1st, 2020 - This article presents the current data supporting adjuvant therapy for patients with cutaneous melanoma. With the recent development of novel immunotherapy agents as well as targeted therapy, there are strong data to support the use of these thera...

see more →

News  211 results

Cutaneous Melanoma Clinical Practice Guidelines (ESMO, 2019)
https://www.medscape.com/viewarticle/920476

Nov 3rd, 2019 - The guidelines on diagnosis, treatment, and follow-up of cutaneous melanoma were released on September 30, 2019 by the European Society for Medical Oncology (ESMO).[1] Diagnosis and Pathology/Molecular Biology Diagnosis should be based on a full-t...

Lifetime indoor tanning raises risk of cutaneous squamous cell carcinoma
https://www.mdedge.com/hematology-oncology/article/209487/nonmelanoma-skin-cancer/lifetime-indoor-tanning-raises-risk?channel=39313
Heidi Splete

Oct 5th, 2019 - Women who accumulated more indoor tanning sessions over time significantly increased their risk for squamous cell cancer over women who never engaged in indoor tanning, based on data from 159,419 women. Previous research has examined associations.

Wide Variability Seen in Number Needed to Biopsy for Cutaneous Melanoma
https://www.medscape.com/viewarticle/915797

Jul 21st, 2019 - NEW YORK (Reuters Health) - The number needed to biopsy (NNB) for cutaneous melanoma varies widely worldwide, and while there isn't a single "ideal" NNB, optimal standards should be developed, researchers say. "The NNB for cutaneous melanoma is an...

Rapidly growing lesions on the forehead
https://www.mdedge.com/familymedicine/article/202581/oncology/rapidly-growing-lesions-forehead/page/0/2?channel=203
MDedge Family Medicine;

Jun 10th, 2019 - This case required a multidisciplinary team The patient underwent magnetic resonance imaging and positron emission tomography/computed tomography; the scans revealed no metastatic disease. She was evaluated by a multidisciplinary head and neck can.

Metastatic or Unresectable Cutaneous Melanoma Clinical Practice Guidelines (2019)
https://www.medscape.com/viewarticle/912214

Apr 28th, 2019 - Guidelines on systemic therapy for metastatic or unresectable cutaneous melanoma and recommendations for adjuvant systemic therapies were released in April 2019 by the National Comprehensive Cancer Network.[1] Systemic Therapy for Metastatic or Un...

see more →